UCB - Celltech Merger - A Strategic Snapshot
UCB - Celltech Merger - A Strategic Snapshot
RELEASE DATE
03-Jun-2004
03-Jun-2004
REGION
Global
Global
Research Code: A988-01-00-00-00
SKU: HC00991-GL-MR_04900
$1,800.00
In stock
SKU
HC00991-GL-MR_04900
Description
The white paper, The UCB-Celltech Merger – A Strategic Snapshot, includes the details of the merger, stock analysis, and product pipeline analysis of Celltech. The white paper includes analysis of Celltech's lead product CDP-870 and its market potential, rheumatoid arthritis and Crohn’s disease market overview, competitive analysis of biologics for rheumatoid arthritis, and impact of the merger on pharmaceutical and biotechnology industry
Table of Contents
UCB-Celltech Merger
- UCB-Celltech Merger - A Strategic Snapshot
Popular Topics
The white paper, The UCB-Celltech Merger A Strategic Snapshot, includes the details of the merger, stock analysis, and product pipeline analysis of Celltech. The white paper includes analysis of Celltech's lead product CDP-870 and its market potential, rheumatoid arthritis and Crohns disease market overview, competitive analysis of biologics for rheumatoid arthritis, and impact of the merger on pharmaceutical and biotechnology industry
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | A988-01-00-00-00 |
Is Prebook | No |